Is There a Generic for Jardiance?

Your pharmacy just handed you a bill for $550+ for a month of Jardiance, and you're wondering why there isn't a cheaper version on the shelf yet. You're not the only one asking. Jardiance (empagliflozin) is one of the most widely prescribed diabetes medications in the country, and the lack of a generic option leaves millions of Americans paying brand-name prices for a drug they may need indefinitely.

Here's where things stand — and what you can actually do about the cost right now.

Why isn't there a generic Jardiance yet?

Jardiance was first approved by the FDA in August 2014. In most cases, brand-name drugs face generic competition within 10–12 years of approval. But Jardiance's manufacturer, Boehringer Ingelheim (in partnership with Eli Lilly), holds multiple patents on empagliflozin — covering the compound itself, specific formulations, and approved uses like heart failure and chronic kidney disease.

Some of these patents extend as far as 2034.

The FDA has granted tentative approval to a handful of generic empagliflozin applications, which means those manufacturers have proven their products are safe and bioequivalent. But "tentative" approval isn't the same as market access.

The most realistic estimate? A widely available generic Jardiance won't hit US pharmacy shelves until 2029 at the earliest, and that timeline could easily shift later depending on patent litigation outcomes.

How much does Jardiance cost without insurance?

The retail price of Jardiance without insurance runs between $550 and $620 per month for either the 10 mg or 25 mg tablet — the price difference between strengths is negligible. That's roughly $6,600–$7,400 per year.

Here's how that breaks down across common scenarios:

Situation	Estimated Monthly Cost
Retail price (no insurance, no coupons)	$550–$620
With GoodRx or similar coupon	$480–$540
With manufacturer savings card (commercial insurance)	As low as $0
Medicare Part D (after deductible)	$50–$150+ depending on plan phase
Through CanAmerica Plus	Significantly less than US retail

Those numbers hit especially hard for patients in the Medicare Part D coverage gap (the "donut hole"), where out-of-pocket costs spike before catastrophic coverage kicks in. Jardiance's high list price means many Medicare patients reach that gap faster than they'd expect.

What is empagliflozin, and how does it work?

Empagliflozin — the active ingredient in Jardiance — belongs to a class of medications called SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). Rather than stimulating insulin production or increasing insulin sensitivity, SGLT2 inhibitors work in the kidneys. They block a protein that normally reabsorbs glucose back into the bloodstream, causing excess sugar to be excreted through urine instead.

The result: lower blood sugar levels without directly affecting insulin.

What makes Jardiance stand out in its class is the breadth of its FDA-approved uses. It's not just a diabetes drug anymore:

• Type 2 diabetes — improving blood sugar control alongside diet and exercise
• Heart failure — reducing the risk of cardiovascular death and hospitalization in adults with heart failure (with or without diabetes)
• Chronic kidney disease — slowing kidney function decline in adults at risk of progression

That triple indication is part of why demand — and the price — stays high. Doctors prescribe it across cardiology, endocrinology, and nephrology, making it one of the most versatile medications in its class.

Jardiance alternatives: other SGLT2 inhibitors to ask about

If Jardiance's price is a barrier, other SGLT2 inhibitors may be worth discussing with your doctor. They work through the same mechanism, though each has slightly different approved indications and pricing.

Medication	Generic Name	Generic Available?	Approximate Monthly Cost
Jardiance	Empagliflozin	No	$550–$620
Farxiga	Dapagliflozin	No (but expected sooner)	$530–$580
Invokana	Canagliflozin	No	$520–$570
Brenzavvy	Bexagliflozin	Yes (brand only, lower cost)	~$69–$150 through select pharmacies
Steglatro	Ertugliflozin	No	$490–$540

Brenzavvy has gotten some attention as a cheaper alternative to Jardiance. It's a different SGLT2 inhibitor (bexagliflozin, not empagliflozin), so it's not a direct generic substitute — but it works through the same pathway.

That said, switching medications isn't always straightforward. Jardiance's specific approval for heart failure and chronic kidney disease means your doctor may have chosen it for reasons beyond blood sugar control. Always talk to your prescriber before making a switch based on cost alone.

How to save on Jardiance right now

Waiting for a generic that's years away doesn't help you fill next month's prescription. Here are the realistic options available today:

Manufacturer savings card

Boehringer Ingelheim offers a Jardiance Savings Card that can bring the copay to $0 for eligible commercially insured patients. The catch: it's only available to people with private or commercial insurance. Medicare, Medicaid, and Tricare beneficiaries don't qualify. And even for those who do, the card typically has an annual cap on benefits.

You can sign up at the official Jardiance website.

Patient assistance programs

Boehringer Ingelheim's Boehringer Cares Foundation provides Jardiance at no cost to qualifying uninsured or underinsured patients. Income limits apply — generally, you'll need to demonstrate financial need. The application process takes some paperwork, but it's worth pursuing if you meet the criteria.

Pharmacy discount coupons

Platforms like GoodRx, RxSaver, and SingleCare offer coupons that can shave $50–$100 off the retail price. That still leaves you paying $480+ per month, so coupons alone rarely solve the affordability problem for uninsured patients. They're most useful as a small supplement to other savings strategies.

Cash Pay Health Networks

This is where the savings math changes significantly. In many countries outside the US, brand-name Jardiance is priced at a fraction of the American retail cost — not because it's a different product, but because other countries negotiate drug prices differently.

Services like CanAmerica Plus connect American patients with licensed providers that dispense the same manufacturer-produced Jardiance at much lower prices. For patients paying out of pocket or stuck in a Medicare coverage gap, this can reduce the annual cost of Jardiance by thousands of dollars.

You'll need a valid US prescription, and shipments typically take 2–4 weeks, so planning ahead matters. But for a medication you take daily and indefinitely, the savings over a year can be substantial.

When will a generic Jardiance be available?

The short answer: not soon enough for most patients.

Here's the patent timeline as it currently stands:

• Core compound patents — some have already expired or are expiring soon
• Use patents (covering specific indications like heart failure) — extend into the early 2030s
• Formulation patents — could block generics until as late as 2034

Generic manufacturers have filed challenges under the Hatch-Waxman Act, and some have received tentative FDA approval. But patent litigation in the pharmaceutical industry moves slowly, and settlements between brand and generic companies sometimes include agreements to delay market entry.

The most widely cited estimate is that the first US generic empagliflozin could launch around 2029. But pharmaceutical patent timelines are notoriously unpredictable — the actual date could shift in either direction.

When generics do arrive, history suggests prices could drop 80–90% within the first year or two of competition. A $550/month medication could eventually cost $30–$60/month as a generic. That's the pattern we've seen with other blockbuster drugs.

The bottom line

There's no generic Jardiance available in the United States in 2026, and the earliest realistic arrival date is 2029. In the meantime, brand-name empagliflozin costs roughly $550–$620/month without insurance — a price that strains budgets whether you're uninsured, underinsured, or stuck in a Medicare coverage gap.

Your best moves right now: check if you qualify for the manufacturer savings card or patient assistance program, ask your doctor whether a cheaper SGLT2 inhibitor like Brenzavvy could work for your situation, and explore cash-pay network pricing through services like CanAmerica Plus for potentially significant savings on the brand-name medication.

Frequently asked questions

Is empagliflozin the same as Jardiance?

Yes. Empagliflozin is the generic name (active ingredient) for Jardiance. They refer to the same medication. However, no generic empagliflozin product is currently available for purchase in the US — the only version you can buy in the US is the brand-name Jardiance manufactured by Boehringer Ingelheim.

What is the cheapest alternative to Jardiance?

Brenzavvy (bexagliflozin) is currently the most affordable SGLT2 inhibitor, available for around $69/month through certain pharmacies. It's not a generic version of Jardiance — it's a different drug in the same class — so your doctor needs to confirm it's appropriate for your condition before switching.

Can I buy generic Jardiance from another country?

Some countries do have generic empagliflozin available at lower prices. Services like CanAmerica Plus work with licensed service providers to lower costs on Jardiance or Empaglifozin.

Does the Jardiance savings card work with Medicare?

No. The manufacturer savings card is only available to patients with commercial or private insurance. Medicare, Medicaid, and other government insurance beneficiaries are excluded. If you're on Medicare, look into the Extra Help program or cash-pay options for potential savings.

Will Jardiance get cheaper when the generic comes out?

History suggests yes — significantly. When generics enter the market for blockbuster drugs, prices typically drop 80–90% within the first two years of competition. A monthly supply that costs $550+ today could eventually cost $30–$60 as a generic. The challenge is that this likely won't happen until 2029 at the earliest.

---

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.